documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
49 rows where docket_id = "FDA-1975-N-0012" and posted_year = 2015 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0012-0636 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Supplement from American Cleaning Institue (ACI) | Other | Supplement (SUP) | 2015-11-20T05:00:00Z | 2015 | 11 | 2015-11-20T05:00:00Z | 2016-03-10T21:51:30Z | 0 | 0 | 0900006481d5fde2 | ||
| FDA-1975-N-0012-0634 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Memorandum of Meeting Minutes from FDA CDER to Lonza America, Inc. | Other | Minutes | 2015-10-23T04:00:00Z | 2015 | 10 | 2015-10-23T04:00:00Z | 2015-10-23T15:08:58Z | 0 | 0 | 0900006481ce5bc0 | ||
| FDA-1975-N-0012-0635 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Advice Letter from FDA CDER to Lewis & Harrison | Other | Letter(s) | 2015-10-23T04:00:00Z | 2015 | 10 | 2015-10-23T04:00:00Z | 2015-10-23T15:12:31Z | 0 | 0 | 0900006481ce5bc1 | ||
| FDA-1975-N-0012-0630 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 8 Volume 2 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:16:48Z | 0 | 0 | 09000064818c25ed | |||
| FDA-1975-N-0012-0622 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 1 Neeper Bradley, T.L. and Kubena, M.F. Developmental Toxicity Evaluation of ADBAC Administered by Gavage to New Zealand Rabbits re Comment from the ADBAC Steering Committee Lewis & Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:14:11Z | 0 | 0 | 09000064818c02c3 | |||
| FDA-1975-N-0012-0632 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 9 Volume 1 of 2 Gill, M.W., et al. Chronic Dietary Oncogenicity Study with ADBAC in Mice re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:17:20Z | 0 | 0 | 09000064818c28cb | |||
| FDA-1975-N-0012-0627 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 6 Selim, Sami Absorption, Distribution, Metabolism and Excretion Studies of ADBAC in the Rat re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:15:32Z | 0 | 0 | 09000064818c222d | |||
| FDA-1975-N-0012-0624 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 3 Neeper Bradley T.L. Developmental Toxicity Evaluation II of ADBAC Administered by Gavage to CD Rats re Comment from the ADBAC Steering Committee Lewis & Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:14:32Z | 0 | 0 | 09000064818c1c56 | |||
| FDA-1975-N-0012-0628 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 7 Neeper Bradley, Theresa L Two Generation Reproduction Study in Sprague Dawley Rats with ADBAC Administered in the Diet re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:15:50Z | 0 | 0 | 09000064818c2427 | |||
| FDA-1975-N-0012-0629 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 8 Volume 1 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:16:37Z | 0 | 0 | 09000064818c25eb | |||
| FDA-1975-N-0012-0625 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 4 Gill, M.W. and Wagner C.L. Ninety Day Subchronic Dermal Toxicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis & Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:14:44Z | 0 | 0 | 09000064818c20a2 | |||
| FDA-1975-N-0012-0626 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 5 Goldenthal, Edwin I. Evaluation of ADBAC in a One Year Chronic Dietary Toxicity Study in Dogs re Comment from the ADBAC Steering Committee Lewis & Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:14:52Z | 0 | 0 | 09000064818c2227 | |||
| FDA-1975-N-0012-0631 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 8 Volume 3 of 3 Gill, M.W., et al. Chronic Dietary Toxicity Oncogenicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:17:06Z | 0 | 0 | 09000064818c25f3 | |||
| FDA-1975-N-0012-0623 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 2 Van Miller, J.P. and Weaver, E.V. Ninety Day Dietary Toxicity Study with ADBAC in Rats re Comment from the ADBAC Steering Committee Lewis & Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:14:21Z | 0 | 0 | 09000064818c1c53 | |||
| FDA-1975-N-0012-0633 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Study 9 Volume 2 of 2 Gill, M.W., et al. Chronic Dietary Oncogenicity Study with ADBAC in Mice re Comment from the ADBAC Steering Committee Lewis and Harrison | Supporting & Related Material | Background Material | 2015-10-21T04:00:00Z | 2015 | 10 | 2016-03-22T19:17:27Z | 0 | 0 | 09000064818c28cd | |||
| FDA-1975-N-0012-0543 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Memorandum of Meeting Minutes Between FDA CDER and American Cleaning Institute on April 24, 2015 | Other | Memorandum | 2015-07-07T04:00:00Z | 2015 | 7 | 2015-07-07T04:00:00Z | 2015-07-07T19:12:21Z | 0 | 0 | 0900006481b6f792 | ||
| FDA-1975-N-0012-0542 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to American Cleaning Institute | Other | Letter(s) | 2015-07-07T04:00:00Z | 2015 | 7 | 2015-07-07T04:00:00Z | 2015-07-07T19:12:15Z | 0 | 0 | 0900006481b6f78f | ||
| FDA-1975-N-0012-0541 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Memorandum of Meeting Minutes Between FDA CDER and American Cleaning Institute | Other | Memorandum | 2015-07-07T04:00:00Z | 2015 | 7 | 2015-07-07T04:00:00Z | 2015-07-07T19:11:58Z | 0 | 0 | 0900006481b6f397 | ||
| FDA-1975-N-0012-0537 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from Lonza, Inc. (Lewis and Harrison) | Other | Letter(s) | 2015-05-20T04:00:00Z | 2015 | 5 | 2015-05-20T04:00:00Z | 2015-05-20T18:57:40Z | 0 | 0 | 0900006481aec6de | ||
| FDA-1975-N-0012-0538 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Attachment 1 Draft Protocol for Uterotrophic re Letter from Lonza Inc Lewis and Harrison | Supporting & Related Material | Background Material | 2015-05-20T04:00:00Z | 2015 | 5 | 2015-05-20T20:21:30Z | 0 | 0 | 0900006481aec0ee | |||
| FDA-1975-N-0012-0539 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Attachment 2 FDA-QSAR for Benzethonium Chloride and Alkyl Dimetylbenzylammonium Chloride re Letter from Lonza Inc Lewis and Harrison | Supporting & Related Material | Background Material | 2015-05-20T04:00:00Z | 2015 | 5 | 2015-05-20T20:21:37Z | 0 | 0 | 0900006481aec0ef | |||
| FDA-1975-N-0012-0540 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Attachment 4 Draft Protocol for Hershberger Bioassay of Benzethonium Chloride USP by Oral in Male Rats re Letter from Lonza Inc Lewis and Harrison | Supporting & Related Material | Background Material | 2015-05-20T04:00:00Z | 2015 | 5 | 2015-05-20T20:21:46Z | 0 | 0 | 0900006481aece32 | |||
| FDA-1975-N-0012-0536 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to Lonza America Inc. Granting Meeting Request regarding Potential Endocrine Effects of Benzethonium Chloride and Benzalkonium Chloride | Other | Letter(s) | 2015-04-24T04:00:00Z | 2015 | 4 | 2015-04-24T04:00:00Z | 2015-04-24T19:44:06Z | 0 | 0 | 0900006481ab9bdc | ||
| FDA-1975-N-0012-0535 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to American Cleaning Institute Granting Meeting Request Regarding Chloroxylenol | Other | Letter(s) | 2015-04-15T04:00:00Z | 2015 | 4 | 2015-04-15T04:00:00Z | 2015-04-16T14:07:15Z | 0 | 0 | 0900006481aa7b59 | ||
| FDA-1975-N-0012-0524 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Supplementary Material Weight of Evidence Framework for EDSP Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:30:33Z | 0 | 0 | 0900006481a95398 | |||
| FDA-1975-N-0012-0532 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix F: Assessment of the Percutaneous Absorption of Chloroxylenol, and Effects of Formulation Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T16:21:32Z | 0 | 0 | 0900006481a970c6 | |||
| FDA-1975-N-0012-0515 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 1 Coalition Melon Ball Disease Transmission Model Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2020-02-07T19:33:21Z | 0 | 0 | 0900006481a95723 | |||
| FDA-1975-N-0012-0518 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 4 Comments Submitted by the American Cleaning Institute and Personal Care Products Council on FDA Proposed Rule for Safety and Effectiveness of Consumer Antiseptics (78 FR 76444-76478; December 17, 2013), Appendix B Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:28:05Z | 0 | 0 | 0900006481a95726 | |||
| FDA-1975-N-0012-0529 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix C: Assessment of the Hormonal Effects Database for Chloroxylenol Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:59:59Z | 0 | 0 | 0900006481a970c3 | |||
| FDA-1975-N-0012-0531 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix E: Assessment of the Pharmacokinetics (ADME) Database for Chloroxylenol Summary of Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T16:15:31Z | 0 | 0 | 0900006481a970c5 | |||
| FDA-1975-N-0012-0516 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 2 Excerpts from Henkel Submission Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:27:13Z | 0 | 0 | 0900006481a95724 | |||
| FDA-1975-N-0012-0520 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 6 Comments Submitted by the American Cleaning Institute and Personal Care Products Council on FDA proposed rule for Safety and Effectiveness of Consumer Antiseptics (78 FR 76444-76478; December 17, 2013), Appendix C Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:29:14Z | 0 | 0 | 0900006481a95728 | |||
| FDA-1975-N-0012-0519 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 5 Schaffner, DW et al. 2014. Quantitative Microbial Risk Assessment of Antibacterial Hand Hygiene Products on the Risk of Shigellosis. Journal of Food Protection. 77(4): 574 - 582 Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2020-02-07T17:27:39Z | 0 | 0 | 0900006481a95727 | |||
| FDA-1975-N-0012-0521 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 7 Final Report Summary BIOHYPO (Confronting the clinical relevance of biocide induced antibiotic resistance) http://cordis.europa.eu/result/rcn/56830 en.html Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:29:33Z | 0 | 0 | 0900006481a95729 | |||
| FDA-1975-N-0012-0528 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix B: Assessment of the Developmental and Reproductive (DART) Database for Chloroxylenol Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:52:04Z | 0 | 0 | 0900006481a970c2 | |||
| FDA-1975-N-0012-0523 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 9 Borgert, C. J., Mihaich, E. M., Ortego, L. S., Bentley, K. S., Holmes, C. M., Levine, S. L. and Becker, R. A. 2011. Hypothesis-driven Weight of Evidence Framework for Evaluating Data within the US EPA's Endocrine Disruptor Screening Program. Regul Toxicol Pharmacal, 61: 185-91 Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:30:13Z | 0 | 0 | 0900006481a95397 | |||
| FDA-1975-N-0012-0527 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix A: Chloroxylenol Antimicrobial Efficacy and ResistanceRe: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:43:08Z | 0 | 0 | 0900006481a970c1 | |||
| FDA-1975-N-0012-0522 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 8 Oggioni. M.R., L. Furi, J.R. Coelho, J-Y. Maillard, J.L. Martinez. 2013. Recent Advances in the Potential Interconnection between Antimicrobial Resistance to Biocides and Antibiotics. Expert Rev Anti Infect Ther. 11(4):363-6 Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:29:52Z | 0 | 0 | 0900006481a9572a | |||
| FDA-1975-N-0012-0525 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Briefing Document from American Cleaning Institute | Other | Brief | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T04:00:00Z | 2015-04-09T15:25:57Z | 0 | 0 | 0900006481a970be | ||
| FDA-1975-N-0012-0526 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 1 Exponent FDA Consumer Antiseptics Rule: FDA Request for Data on Safety and Efficacy of ChloroxylenolRe: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:39:47Z | 0 | 0 | 0900006481a970c0 | |||
| FDA-1975-N-0012-0530 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix D: Assessment of the Mutagenic and Carcinogenic Effects for Chloroxylenol Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T16:06:07Z | 0 | 0 | 0900006481a970c4 | |||
| FDA-1975-N-0012-0517 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 3 Boyce, J.M et al. 2012. An Expert Panel Report of a Proposed Scientific Model Demonstrating the Effectiveness of Antibacterial Handwash Products. American Journal of Infection Control, 40: 742-9 Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T15:27:37Z | 0 | 0 | 0900006481a95725 | |||
| FDA-1975-N-0012-0534 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | APPENDIX 3 Sanderson H, Counts JL, Stanton KL, Sedlak Rl. 2006. Exposure and Prioritization-Human Screening Data and Methods for High Production Volume Chemicals in Consumer Products: Amine oxides, A Case Study Risk Analysis 26:1637-1657 Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T16:33:36Z | 0 | 0 | 0900006481a9710b | |||
| FDA-1975-N-0012-0533 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Appendix 2 Risk Assessment of Chloroxylenol in Liquid Hand Soap Used by Consumers and Health-Care Providers Re: Briefing Document from American Cleaning Institute | Supporting & Related Material | Background Material | 2015-04-09T04:00:00Z | 2015 | 4 | 2015-04-09T16:27:58Z | 0 | 0 | 0900006481a970c7 | |||
| FDA-1975-N-0012-0514 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Briefing Document from American Cleaning Institute | Other | Brief | 2015-04-08T04:00:00Z | 2015 | 4 | 2015-04-08T04:00:00Z | 2015-04-08T18:34:17Z | 0 | 0 | 0900006481a95600 | ||
| FDA-1975-N-0012-0513 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA/CDER to Personal Care Products Council and American Cleaning Institute Granting Meeting Request | Other | Letter(s) | 2015-03-09T04:00:00Z | 2015 | 3 | 2015-03-09T04:00:00Z | 2015-03-09T14:35:15Z | 0 | 0 | 0900006481a33f3d | ||
| FDA-1975-N-0012-0512 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Interim Response Letter from FDA CDER to the American Cleaning Institute and Personal Care Products Council | Other | Letter(s) | 2015-02-27T05:00:00Z | 2015 | 2 | 2015-02-27T05:00:00Z | 2015-05-20T18:41:10Z | 0 | 0 | 0900006481a1e054 | ||
| FDA-1975-N-0012-0511 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from the Personal Care Products Council and American Cleaning Institute to FDA/CDER re Letter from the Personal Care Products Council Covington and Burling LLP | Supporting & Related Material | Background Material | 2015-01-07T05:00:00Z | 2015 | 1 | 2015-01-07T22:09:32Z | 0 | 0 | 09000064819ac234 | |||
| FDA-1975-N-0012-0510 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from the Personal Care Products Council Covington & Burling LLP | Other | Letter(s) | 2015-01-07T05:00:00Z | 2015 | 1 | 2015-01-07T05:00:00Z | 2015-01-07T22:04:35Z | 0 | 0 | 09000064819ac1ee |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);